IDeate-Prostate01 will enroll approximately 1,440 ... (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities ...

IDeate-Esophageal01 will enroll approximately 510 ... (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities ...

IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer Aug. 01, 2024 8:00 AM ET Merck & Co., Inc. (MRK) , DSNKY Q2: 2024-07-30 Earnings Summary ...

I-DXd, a B7-H3–directed antibody–drug conjugate, demonstrated promising efficacy in the ongoing Phase 1/2 IDeate-Pantumor01 study, with a confirmed objective response rate (ORR) of 52.4% and a ...

Cheshire-based digital marketing agency Pretzel Group has rebranded to Ideate Digital aligning the business with its current proposition ... Starting 2025 as we mean to go on, ...

IDeate-Prostate01 will enroll approximately 1,440 ... (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities ...

BASKING RIDGE, N.J. & RAHWAY, N.J., May 19, 2025--The first patient has been dosed in the IDeate-Esophageal01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab ...

IDeate-Esophageal01 will enroll approximately 510 ... (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities ...